Recent News

• 03.30.2026 - BTX User Spotlight: Investigating the Role of CHD1L in Neurodevelopment
• 03.17.2026 - Choosing a Quality Syringe Pump for Your Lab: What Really Matters
• 03.12.2026 - Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results
• 03.06.2026 - Harvard Bioscience Announces Reverse Stock Split
• 03.03.2026 - Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum
• 02.26.2026 - Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET
• 02.24.2026 - Beyond the Petri Dish: 4 Organoid MEA Studies Redefining What’s Possible

Recent Filings

• 03.23.2026 - SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership
• 03.23.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.17.2026 - 8-K Current report
• 03.17.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.17.2026 - EX-99.1 EX-99.1
• 03.13.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.12.2026 - EX-99.1 EX-99.1
• 03.12.2026 - 8-K Current report